1
|
Lau JCC, McCluggage WG, Yuen LYP, Shing MMK, Chan GCF, Yam FSD, Leung MWY, Ng WF, Liu APY. DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case. Int J Gynecol Pathol 2023; 42:421-425. [PMID: 36044308 DOI: 10.1097/pgp.0000000000000902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
We report an unusual case of a pelvic extraovarian moderately differentiated Sertoli-Leydig cell tumor arising in a 4-yr-old female. The tumor contained a DICER1 pathogenic variant which was absent in the germline ruling out DICER1 syndrome. In reporting this case, we discuss the differential diagnosis and possible histogenesis and review reported cases of extraovarian Sertoli-Leydig cell tumor.
Collapse
|
2
|
Terry W, Carlisle EM, Mallinger P, Nelson A, Gordon D, Messinger YH, Field A, Dehner LP, Hill DA, Schultz KAP. Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatr Blood Cancer 2021; 68:e29284. [PMID: 34398502 PMCID: PMC8463509 DOI: 10.1002/pbc.29284] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 07/23/2021] [Accepted: 07/28/2021] [Indexed: 11/08/2022]
Abstract
A 2-year-old boy presented with a large cystic and solid chest mass arising from the lung, radiographically consistent with pleuropulmonary blastoma (PPB). He underwent right lower lobectomy with resection of a well-circumscribed, mixed solid and cystic mass. The solid areas were composed of cords and nests of tumor cells in the myxoid stroma and retiform foci whose pathologic and immunophenotypic findings were consistent with a sex cord-stromal tumor with features of a Sertoli-Leydig cell tumor. Tumor testing showed a pathogenic variant in the DICER1 RNase IIIb hotspot domain. Family history was suggestive of DICER1 germline pathogenic DICER1 variation in absence of a detectable germline variant. He received 12 cycles of chemotherapy with ifosfamide, vincristine, dactinomycin and doxorubicin (IVADo) and surgery with complete response. One year after completion of chemotherapy, imaging studies showed concern for recurrence confirmed by thorascopic biopsy of a pleural-based mass. He is currently receiving cisplatin-based chemotherapy with reduction in tumor size. Review of the literature showed no similar cases; however, review of our pathology files revealed a single similar case of anterior mediastinal Sertoli cell tumor in a 3-year-old girl.
Collapse
Affiliation(s)
- William Terry
- Division of Pediatric Hematology/Oncology, Stead Family Children’s Hospital, Iowa City, IA
| | - Erica M. Carlisle
- Division of Pediatric Surgery, Stead Family Children’s Hospital, Iowa City, IA
| | - Paige Mallinger
- International PPB/DICER1 Registry, Children’s Minnesota, Minneapolis, MN,International Ovarian and Testicular Stromal Tumor Registry, Children’s Minnesota, Minneapolis, MN,Cancer and Blood Disorders, Children’s Minnesota, Minneapolis, MN
| | - Alexander Nelson
- International PPB/DICER1 Registry, Children’s Minnesota, Minneapolis, MN,International Ovarian and Testicular Stromal Tumor Registry, Children’s Minnesota, Minneapolis, MN,Cancer and Blood Disorders, Children’s Minnesota, Minneapolis, MN
| | - David Gordon
- Division of Pediatric Hematology/Oncology, Stead Family Children’s Hospital, Iowa City, IA
| | - Yoav H. Messinger
- International PPB/DICER1 Registry, Children’s Minnesota, Minneapolis, MN,International Ovarian and Testicular Stromal Tumor Registry, Children’s Minnesota, Minneapolis, MN,Cancer and Blood Disorders, Children’s Minnesota, Minneapolis, MN
| | | | - Louis P. Dehner
- Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University Medical Center, St. Louis, MO
| | - D. Ashley Hill
- Department of Pathology and Laboratory Medicine, Children’s National Medical Center, Washington, DC
| | - Kris Ann P. Schultz
- International PPB/DICER1 Registry, Children’s Minnesota, Minneapolis, MN,International Ovarian and Testicular Stromal Tumor Registry, Children’s Minnesota, Minneapolis, MN,Cancer and Blood Disorders, Children’s Minnesota, Minneapolis, MN
| |
Collapse
|
3
|
Al Harbi R, McNeish IA, El-Bahrawy M. Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management. Int J Gynecol Cancer 2021; 31:161-168. [PMID: 33414107 DOI: 10.1136/ijgc-2020-002018] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Revised: 11/24/2020] [Accepted: 11/30/2020] [Indexed: 12/17/2022] Open
Abstract
Sex cord stromal-tumors are rare tumors of the ovary that include numerous tumor subtypes of variable histological features and biological behavior. Surgery is the main therapeutic modality for the management of these tumors, while chemotherapy and hormonal therapy may be used in some patients with progressive and recurrent tumors. Several studies investigated molecular changes in the different tumor types. Understanding molecular changes underlying the development and progression of sex cord-stromal tumors provides valuable information for diagnostic and prognostic biomarkers and potential therapeutic targets for these tumors. In this review, we provide an update on the clinical presentation, molecular changes, and management of sex cord-stromal tumors.
Collapse
Affiliation(s)
- Rehab Al Harbi
- Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, UK
| | - Iain A McNeish
- Department of Surgery and Cancer, Imperial College London, London, UK
| | - Mona El-Bahrawy
- Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, UK .,Department of Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
| |
Collapse
|